Hello, I'm new to this site but not new to diabetes as I have been injecting for over 42 years. I'm wondering whether anyone else has had trouble being prescribed the Omnipod on the NHS? I have an appointment with my clinic at the end of the month so I don't know definitely, but it seems likely that I will have to wait several years to be prescribed this. It feels like a no brainer to me, and I thought I would be prescribed immediately, but it seems to be a resource issue in that I haven't met the criteria yet. You have to have a predicted HBA1 of 7.5 or above, which is exactly mine and they then prioritised children and pregnant women, or women trying to get pregnant (and at 68 I can't argue that!). I'm just wondering what arguments to advance. (One is that I've just been diagnosed with sleep apnea, which seems to have thrown my control out a bit.) If I can't get it, is there any other alternative to buying it until I reach the top of the list? I have been quoted over £370 per month, which is a huge amount for something that should be available on the NHS. Thank you - any advice/ experience welcome. Poll
The funding is there. According to the NHS England diabetes technology lead, that money has been ringfenced.
There are four main problems.
First, NICE, the clinical organisation that set the criteria for the implementation of hybrid closed loops, have allowed five years for NHS England, hospital trusts and integrated care systems to roll out the technology to everyone eligible. Which means the NHS in England doesn't have to complete the rollout to everyone eligible until, roughly, 2029/2030.
NHS England set the patients who are supposed to get "priority." In the first year of the rollout (2024/25) the priority was to put under 18s, pregnant women and those trying to get pregnant on hybrid closed loops. That group hasn't been finished as the NHS in England begins its second financial year of the rollout.
The priority group for the second financial year (2025/26) set by NHS England is marginally wider, but still doesn't cover everyone eligible.
In the first year NHS England envisaged that outside of under 18s, the pregnant and wanting to get pregnant, no more than 500 completely "new" starters in England would receive a hybrid closed loop.
Even if you meet the criteria set out in the NICE technical appraisal document; and even if you are suffering from diabetes complications that might be improved significantly if you were given a hybrid closed loop; many local health authorities appear to be sticking rigidly to the priority set by NHS England for the rollout.
The process and procedure for the hybrid closed loop rollout at present is such that, for example, it is irrelevant that you might be suffering from eye or vascular complications that would be improved significantly if you were put on a hybrid closed loop, because NHS England and local health authorities are adhering religiously to "priority" groups.
The second problem is that there aren't enough trained NHS staff to train patients on proper use of their hybrid closed loops.
The third problem is the bureaucracy involved. If you don't fall into any of the groups that NHS England consider to be a priority, your diabetic team have to make a "special" case for why you should be funded. I understand that making that case involves completing a 30 page form (I understand that this document isn't even in electronic format, but has to be completed in manuscript form) and it involves getting sign off from your local integrated care system, who provide the money for one or both of the components that comprise the hybrid closed loop.
Can you imagine having to complete a 30 page form - by hand - for every patient who doesn't fall within the priority categories identified by NHS England and make a compelling case for why that patient is deserving of a hybrid closed loop, while still "doing the usual day job" of looking after sick patients on wards, outpatient clinics or in the community?
As far as the Omnipod 5 is concerned, your local health authority in England is unlikely to fund your use of the Dexcom G6 cgm with the Omnipod 5, because it is more expensive than the Libre 2 Plus cgm. This is despite the fact that there is numerous evidence from users that there are significant connectivity issues between the Omnipod 5 pod and the Libre 2 Plus cgm and that the Dexcom G6 has significantly less connection issues with the Omnipod 5.
NHS England haven't even finalised a price with Dexcom for their G7 cgm, which recently became integrated with the Omnipod 5.
The fourth problem is that, as usual, there is a postcode lottery going on across England, which is a mixture of local health authorities not wanting to fund hybrid closed loops, and/or fund particular continuous glucose monitors, bureaucracy, lack of staff.
At the end of roughly 2029/2030, if you meet the criteria set out by NICE in their hybrid closed loop technical appraisal document and you still haven't received a hybrid closed loop you may have a good case to consider and take legal action (assuming of course that one has the financial means, the time and the energy to even consider legal action, bearing in mind that the NHS has on retainer some of the best healthcare lawyers in the country to defend itself when they get sued by patients) against your local health authority for failing to comply with the NICE technical appraisal document concerning the rollout of hybrid closed loops. For now, all you can do if you aren't considered to be part of the priority "group" is encourage, plead, badger and cajole someone in your diabetes team to get you onto a hybrid closed loop sooner rather than later.
Yes, I also understand the price of the Omnipod 5 is what you say it is if you pay privately (anyone paying privately would still need a diabetes consultant to confirm that a hybrid closed loop would benefit the person paying privately). I assume the £370 does not include the cost of continuous glucose monitors, which would be an additional cost (if the NHS isn't funding your cgms already). But why should you pay for the pods if you meet the NICE criteria?